Login

BehindtheBell: Pctel CEO David Neumann discusses company updates and strategies with Paul Southwell. 00:10:00

Share On Facebook Share On Twitter

PCTEL's Chief Executive Officer is David Neumann.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Client Recognizes Real Business Value | Filip J L Gyde, CEO, Computer Task Group Inc TSK:BER
00:10:00
Exploring Global Ventures: An Interview with Marco Soriano, CEO of Soriano Group
00:10:00
UiPath Co-CEO Robert Enslin discusses the future of workplace automation with Assistant Managing Editor Diane Brady.
00:10:00
NSW Digital Infrastructure Energy Flexibility (DIEF) Project with CSIRO's Data Clearing House (DCH) Platform | Dr Doug Hilton AO, CEO of CSIRO Mineral Resources
00:10:00
Exploring the Mysteries of the Universe and Greenland: A Conversation with Lawrence Krauss|Lawrence Krauss,Professor,Arizona State University
00:10:00
BigCommerce CEO Brent Bellm appears on "Squawk Alley" ahead of the company's public debut.|Brent is the Chief Executive Officer of BigCommerce.
00:10:00
Atlas Energy to build a 42 mile conveyor belt | John Turner, CEO, Atlas Energy Solutions IncAESI:NYQ
00:00:00
Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:10:00
Exclusive Interview: Richard Youle, Co-Head of Private Equity at Skadden Arps, Shares Insights | John Slate - Founder of Skadden
00:10:00
Gordon Bajnai, Chairman, Global Advisory Board, Campbell Lutyens
00:10:00
growing is importance in the global Fintech landscape|Andrew Endicott,Founding Partner,Gilgamesh Ventures
00:10:00
"2024 Global Investment Outlook | Insights from BlackRock's Wei Li"

© 2026 Nehu